Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (4): 378-382.doi: 10.3736/jcim20070404
• Commentary • Previous Articles Next Articles
Huan-rong Li1,Xiu-rong Li2
CLC Number:
[1] | O'Reilly MS , Holmgren L, Shing OY, et al.Angiostatin, a novel angiogenesis inhibitor that mediates the suppression of metastasis by Leweis lung cancer[J]. Cell, 1994,79(2):315-328 |
[2] | 周俊 . 中药复方——天然组合化学库与多靶作用机理[J]. 中国中西医结合杂志, 1998,18(2):67 |
Zhou J . Composite recipe of Chinese medicines, the natural combination of chemicals, and mechanism of multi-target action[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1998,18(2):67 | |
[3] | 范跃祖, 陈春球, 赵泽明 , 等. 去甲斑蝥素对胆囊癌肿瘤血管生成的作用及机制研究[J]. 中华医学杂志, 2006,86(10):693-699 |
Fan YZ, Chen CQ, Zhao ZM , et al. Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms[J]. Zhonghua Yi Xue Za Zhi, 2006,86(10):693-699 | |
[4] | 张妮娜, 卜平, 朱海杭 , 等. 半枝莲抑制肿瘤血管生成的作用及其机制研究[J]. 癌症, 2005,24(12):1459-1463 |
Zhang NN, Bu P, Zhu HH , et al. Inhibitory effects of Scutellaria barbatae D. Don on tumor angiogenesis and its mechanism[J]. Ai Zheng, 2005,24(12):1459-1463 | |
[5] |
Wang S, Zheng Z, Weng Y , et al. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts[J]. Life Sci, 2004,74(20):2467-2478
doi: 10.1016/j.lfs.2003.03.005 pmid: 15010258 |
[6] | 何振辉, 何太平, 莫丽儿 , 等. 白藜芦醇与半边旗二萜类化合物5F对活体血管生成的影响[J]. 实用医技杂志, 2006,13(1):1-3 |
He ZH, He TP, Mo LE , et al. Effect of resveratrol and the diterperoid compound 5F isolated from Pteris semipinnata L on angiogenesis in vivo[J]. Shi Yong Yi Ji Za Zhi, 2006,13(1):1-3 | |
[7] | Brekken RA, Overholser JP, Stastny VA , et al. Selective inhibition of vascular endothelial growth factor(VEGF) receptor 2(KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice[J]. Cancer Res, 2000,60(18):5117-5124 |
[8] | 颜大海, 朱树林, 付宝忠 . 鸡胚法筛选具有血管生成抑制作用中药[J]. 黑龙江医药, 1998,11(2):94 |
Yan DH, Zu SL, Fu BZ . Screening of anti-angiogenesis Chinese medicine by chicken embryo[J]. Heilongjiang Yi Yao, 1998,11(2):94 | |
[9] | 徐中平, 李福川, 王海仁 . 昆布多糖硫酸酯的抑制血管生成和抗肿瘤作用[J]. 中草药, 1999,30(7):551-553 |
Xu ZP, Li FC, Wang HR . Functions of laminarin sulphate in anti-angiogenesis and anti-tumor[J]. Zhong Cao Yao, 1999,30(7):551-553 | |
[10] | 王志玲 . 饮茶抑制血管生成[J]. 国外医学卫生学分册, 2000,27(3):190 |
Wang ZL . Drinking tea inhibits angiogenesis[J]. Guo Wai Yi Xue Wei Sheng Xue Fen Ce, 2000,27(3):190 | |
[11] | 徐瑞成, 陈小义, 陈莉 , 等. Bufalin抗癌机制研究进展[J]. 国外医学肿瘤学分册, 2000,27(4):202-204 |
Xu RC, Chen XY, Chen L , et al. Mechanism research progress of bufalin in anti-cancer[J]. Guo Wai Yi Xue Zhong Liu Xue Fen Ce, 2000,27(4):202-204 | |
[12] | Shinkai K, Akedo H, Mukai M . Inhibition of in vitro tumor cell invasion by ginsenoside Rg3[J]. Jpn J Cancer Res, 1996,87(4):357-362 |
[13] | Mochizuki M, Yung CY, Kaori M . Inhibition effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-insenoside-Rg3, of red ginseng[J]. Biol Pharm Bull, 1995,18(9):1197-1202 |
[14] | 高勇, 王杰军, 许青 , 等. 人参皂苷Rg3抑制肿瘤新生血管形成的研究[J]. 第二军医大学学报, 2001,22(1):40 |
Gao Y, Wang JJ, Xu Q , et al. Inhibitory effect of ginsenoside Rg3 on tumor neoangiogenesis[J]. Di Er Jun Yi Da Xue Xue Bao, 2001,22(1):40 | |
[15] | 潘子民, 叶大风, 谢幸 , 等. 人参皂苷Rg3对荷卵巢癌的严重联合免疫缺陷鼠的抗肿瘤血管生成作用的研究[J]. 中华妇产科杂志, 2002,37(4):227-230 |
Pan ZM, Ye DF, Xie X , et al. Antiangiogenesis of ginsenoside Rg3 in severe combined immunodeficient mice with human ovarian carcinoma[J]. Zhonghua Fu Chan Ke Za Zhi, 2002,37(4):227-230 | |
[16] | 李大鹏 . 康莱特注射液抗癌作用机理研究进展[J]. 中药新药与临床药理, 2001,12(2):122-124 |
Li DP . Mechanism research progress of Kanglaite Injection in anti-cancer[J]. Zhong Yao Xin Yao Yu Lin Chuang Yao Li, 2001,12(2):122-124 | |
[17] | 姜晓玲, 张良, 徐卓玉 , 等. 薏苡仁注射液对血管生成的影响[J]. 肿瘤, 2000,20(4):313-314 |
Jiang XL, Zhang L, Xu ZY , et al. The influence of Semen Coicis Injection on angiogenesis[J]. Zhongliu, 2000,20(4):313-314 | |
[18] | 高勇, 王杰军, 梅长林 , 等. 红素抑制血管生长的实验研究[J]. 肿瘤, 1998,18(4):280-281 |
Gao Y, Wang JJ, Mei CL , et al. Experimental research of tripterine in inhibiting angiogenesis[J]. Zhong Liu, 1998,18(4):280-281 | |
[19] | 陈世壮, 计磊, 王玉萍 , 等. 红素对大鼠肝脏内皮细胞的体外杀伤作用[J]. 前卫医药杂志, 1999,16(6):337-339 |
Chen SZ, Ji L, Wang YP , et al. Damaging effect on rat liver endothelial cells of tripterine in vitro[J]. Qian Wei Yi Yao Za Zhi, 1999,16(6):337-339 | |
[20] | 陈达理, 张绪慧 . 鳖甲煎丸抗肿瘤血管生成的实验研究[J]. 浙江中医杂志, 2004,39(12):535-537 |
Chen DL, Zhang XH . Experimental study on anti-angiogenesis in tumor of Biejiajie Pills[J]. Zhejiang Zhong Yi Za Zhi, 2004,39(12):535-537 | |
[21] | 刘鲁明, 林胜友 . 参麦注射液对恶性肿瘤化学药物治疗增效减毒作用的临床和实验研究[J]. 中国肿瘤, 1993,2(9):22 |
Liu LM, Lin SY . Experimental and clinical study on attenuated synergies of chemical medicine by Shenmai Injection[J]. Zhongguo Zhong Liu, 1993,2(9):22 | |
[22] | 尹丽慧, 高承贤, 丁志山 , 等. 参麦注射液对牛内皮细胞增殖抑制作用的实验研究[J]. 浙江中医学院学报, 2002,26(2):48-50 |
Yin LH, Gao CX, Ding ZS , et al. An experimental study on the inhibiting effect of Shenmai Injection on endothelial cell proliferation[J]. Zhejiang Zhong Yi Xue Yuan Xue Bao, 2002,26(2):48-50 |
[1] | Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384. |
[2] | Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364. |
[3] | Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192. |
[4] | Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212. |
[5] | Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134. |
[6] | Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477. |
[7] | Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394. |
[8] | Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438. |
[9] | Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294. |
[10] | Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299. |
[11] | Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281. |
[12] | Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231. |
[13] | Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202. |
[14] | Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225. |
[15] | Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190. |